Skip to main content
SpringerLink
Log in

MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis

  • Research Article
  • Published:
Human Cell Aims and scope Submit manuscript

Abstract

Numerous studies demonstrated that microRNAs (miRNAs) were highly involved in pancreatic cancer development. However, the functional roles of many miRNAs remain elusive in pancreatic cancer. In the present study, we analyzed previous published microarray data and found that miR-1469-5p was one of top upregulated miRNAs in pancreatic tumors. Our further study showed that miR-1469-5p was highly expressed in collected pancreatic tumors and its upregulation was associated with lymph node metastasis and tumors of advanced TNM stage. Functional analysis with miR-1469-5p inhibitor showed that downregulation of miR-1469-5p repressed pancreatic cancer cell proliferation and invasion. Mechanistically, miR-1469-5p directly interacted with metastasis suppressor NDRG1 mRNA and downregulated expression of NDRG1 to activate NF-κB pathway in pancreatic cancer cells. It was also found that miR-1469-5p decreased expression of E-cadherin, a metastasis related gene repressed by NF-κB pathway, in pancreatic cancer cells. Transfection of NDRG1 small interference RNA (siRNA) attenuated the function of miR-1469-5p inhibitor in pancreatic cancer cells. Moreover, miR-1469-5p expression was negatively associated with NDRG1 and E-cadherin mRNA levels in pancreatic tumors. Taken together, miR-1469-5p may exert its oncogenic potential in pancreatic cancer via regulating a NDRG1/NF-κB/E-cadherin axis, suggesting that it may be clinically valuable as a prognostic biomarker of pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article.

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

    Article  Google Scholar 

  2. Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10–27.

    Article  Google Scholar 

  3. Kleeff J, Reiser C, Hinz U, et al. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg. 2007;245:566–72.

    Article  Google Scholar 

  4. Lemke J, Scheele J, Kapapa T, Wirtz CR, Henne-Bruns D, Kornmann M. Brain metastasis in pancreatic cancer. Int J Mol Sci. 2013;14:4163–73.

    Article  CAS  Google Scholar 

  5. Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004.

    Article  Google Scholar 

  6. Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: a miRNA expression analysis. Gene. 2018;673:181–93.

    Article  CAS  Google Scholar 

  7. Wu G, Li Z, Jiang P, et al. MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. Oncotarget. 2017;8:82854–71.

    Article  Google Scholar 

  8. Slotwinski R, Lech G, Slotwinska SM. MicroRNAs in pancreatic cancer diagnosis and therapy. Cent Eur J Immunol. 2018;43:314–24.

    Article  CAS  Google Scholar 

  9. Song C, Chen T, He L, et al. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. Cell Oncol (Dordr). 2020;43:51–62.

    Article  CAS  Google Scholar 

  10. Peng L, Liu Z, Xiao J, et al. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/beta-catenin signaling pathway. Oncol Rep. 2017;38:301–8.

    Article  CAS  Google Scholar 

  11. Ouyang H, Gore J, Deitz S, Korc M. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions. Oncogene. 2017;36:4952.

    Article  CAS  Google Scholar 

  12. Shimomura A, Shiino S, Kawauchi J, et al. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 2016;107:326–34.

    Article  CAS  Google Scholar 

  13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.

    Article  CAS  Google Scholar 

  14. Pramanik KC, Makena MR, Bhowmick K, Pandey MK. Advancement of NF-κB signaling pathway: a novel target in pancreatic cancer. Int J Mol Sci. 2018;19:3890.

    Article  Google Scholar 

  15. Zhou P, Wang C, Hu Z, Chen W, Qi W, Li A. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway. BMC Cancer. 2017;17:813.

    Article  Google Scholar 

  16. Pires BR, Mencalha AL, Ferreira GM, et al. NF-kappaB is involved in the regulation of EMT genes in breast cancer cells. PLoS ONE. 2017;12:e0169622.

    Article  Google Scholar 

  17. Menezes SV, Fouani L, Huang MLH, et al. The metastasis suppressor, NDRG1, attenuates oncogenic TGF-beta and NF-kappaB signaling to enhance membrane E-cadherin expression in pancreatic cancer cells. Carcinogenesis. 2019;40:805–18.

    Article  CAS  Google Scholar 

  18. Liu J, Wang C, Liu X, et al. Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer. Oncol Lett. 2017;13:4469–74.

    Article  CAS  Google Scholar 

  19. Ma CH, Zhang YX, Tang LH, et al. MicroRNA-1469, a p53-responsive microRNA promotes Genistein induced apoptosis by targeting Mcl1 in human laryngeal cancer cells. Biomed Pharmacother. 2018;106:665–71.

    Article  CAS  Google Scholar 

  20. Zhang Y, Fang J, Zhao H, Yu Y, Cao X, Zhang B. Downregulation of microRNA-1469 promotes the development of breast cancer via targeting HOXA1 and activating PTEN/PI3K/AKT and Wnt/beta-catenin pathways. J Cell Biochem. 2019;120:5097–107.

    Article  CAS  Google Scholar 

  21. Botla SK, Savant S, Jandaghi P, et al. Early epigenetic downregulation of microRNA-192 expression promotes pancreatic cancer progression. Cancer Res. 2016;76:4149–59.

    Article  CAS  Google Scholar 

  22. Liu J, Shao Y, He Y, et al. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1. Cancer Sci. 2019;110:135–46.

    Article  CAS  Google Scholar 

  23. Park KC, Paluncic J, Kovacevic Z, Richardson DR. Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer. Free Radic Biol Med. 2019;24:30256.

    Google Scholar 

  24. Chen Z, Sun J, Li T, et al. Iron chelator-induced up-regulation of Ndrg1 inhibits proliferation and EMT process by targeting Wnt/beta-catenin pathway in colon cancer cells. Biochem Biophys Res Commun. 2018;506:114–21.

    Article  CAS  Google Scholar 

  25. Chen K, Liu XH, Wang FR, Liu HP, Huang ZP, Chen X. The prognostic value of decreased NDRG1 expression in patients with digestive system cancers: a meta-analysis. Med (Baltimore). 2018;97:e12455.

    Article  CAS  Google Scholar 

  26. Liu W, Zhang B, Hu Q, et al. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: suppression of glycolytic metabolism. Int J Oncol. 2017;50:1792–800.

    Article  CAS  Google Scholar 

  27. Zeng F, Wang Q, Wang S, et al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene. 2020;39:293–307.

    Article  CAS  Google Scholar 

  28. Qiu L. MiR-449a suppresses endometrial cancer invasion and metastasis by targeting NDRG1. Ann Oncol. 2018;29:811.

    Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Linyi Cancer Hospital, Linyi, Shandong, China

    Jinju Liu, Lingzhi Zhang, Hongmei Lu, Zhen Wang & Jian Lv

  2. Department of Abdominal Surgery, Linyi Cancer Hospital, Linyi, Shandong, China

    Chaoyu Zhu & Changru Fan

Authors
  1. Jinju Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chaoyu Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lingzhi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hongmei Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jian Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Changru Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design: CF; Development of methodology: JL, CZ, LZ; Acquisition and analysis of data: JL, CZ, LZ, HL, ZW, JL; Writing and revision of manuscript: JL, CF; Study supervision: CF. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Changru Fan.

Ethics declarations

Conflict of interests

The authors declare that there are no competing interests.

Ethical standards

The study was performed in accordance with the Declaration of Helsinki. The protocol of the current study was approved by the Ethics Committee of Linyi Cancer Hospital (Approval number: LYCH20160905).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Zhu, C., Zhang, L. et al. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis. Human Cell 33, 1176–1185 (2020). https://doi.org/10.1007/s13577-020-00399-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13577-020-00399-7

Keywords

Search

Navigation